{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:57:40Z","timestamp":1772474260749,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00393-026-01786-5","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T13:44:21Z","timestamp":1771940661000},"page":"126-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Entz\u00fcndliche Dermatosen bei der adulten chronisch nicht-bakteriellen Osteitis aus dermatologischer Perspektive","Inflammatory dermatosis in adult chronic non-bacterial osteomyelitis (adult CNO) from a dermatological perspective"],"prefix":"10.1007","volume":"85","author":[{"given":"Mareike","family":"Alter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia S. L.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Pfoehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunter","family":"Assmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Susok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"2","key":"1786_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/ard-2024-226446","volume":"84","author":"E Winter","year":"2025","unstructured":"Winter\u00a0E, Dekkers\u00a0O, Andreasen\u00a0C, D\u2019Angelo\u00a0S, Appelman-Dijkstra\u00a0N, Appenzeller\u00a0S, Assmann\u00a0G et\u00a0al (2025) Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults. Ann Rheum Dis 84(2):169\u2013187","journal-title":"Ann Rheum Dis"},{"key":"1786_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","volume":"26","author":"E Christophers","year":"2001","unstructured":"Christophers\u00a0E (2001) Psoriasis \u2013 Epidemiology and clinical spectrum. Clin Exp Dermatol 26:314\u2013314","journal-title":"Clin Exp Dermatol"},{"key":"1786_CR3","doi-asserted-by":"crossref","unstructured":"O\u2019Daly JA (2012) Psoriasis \u2013 a\u00a0systemic disease 163-165","DOI":"10.5772\/2472"},{"issue":"11","key":"1786_CR4","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1093\/jbmr\/zjae141","volume":"39","author":"E Roberts","year":"2024","unstructured":"Roberts\u00a0E, Charras\u00a0A, Hahn\u00a0G, Hedrich\u00a0CM (2024) An improved understanding of pediatric chronic nonbacterial osteomyelitis pathophysiology informs current and future treatment. J\u00a0Bone Miner Res 39(11):1523\u20131538","journal-title":"J Bone Miner Res"},{"key":"1786_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1427784","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang\u00a0Y, Chen\u00a0Q, Zhong\u00a0W (2024) The role of cytokines in the pathogenesis of SAPHO syndrome. Front Immunol 15:1427784","journal-title":"Front Immunol"},{"issue":"1","key":"1786_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1546-0096-11-47","volume":"11","author":"CM Hedrich","year":"2013","unstructured":"Hedrich\u00a0CM, Hofmann\u00a0SR, Pablik\u00a0J, Morbach\u00a0H, Girschick\u00a0HJ (2013) Autoinflammatory bone disorders with special focus on chronic recurrent multifocal osteomyelitis (CRMO). Pediatr Rheumatol Online J 11(1):47\u201347","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"1786_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-022-01288-3","volume":"13","author":"N MAC","year":"2022","unstructured":"MAC\u00a0N, Ara\u00fajo\u00a0FF, Guimar\u00e3es\u00a0JB, da Cruz\u00a0IAN, Silva\u00a0FD, Carneiro\u00a0BC, Filho\u00a0AGO (2022) Chronic nonbacterial osteomyelitis: the role of whole-body MRI. Insights Imaging 13(1):149","journal-title":"Insights Imaging"},{"issue":"1","key":"1786_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-021-01059-6","volume":"12","author":"MC Schaal","year":"2021","unstructured":"Schaal\u00a0MC, Gendler\u00a0L, Ammann\u00a0B, Eberhardt\u00a0N, Janda\u00a0A, Morbach\u00a0H, Darge\u00a0K, Girschick\u00a0H, Beer\u00a0M (2021) Imaging in non-bacterial osteomyelitis in children and adolescents: diagnosis, differential diagnosis and follow-up-an educational review based on a\u00a0literature survey and own clinical experiences. Insights Imaging 12(1):113","journal-title":"Insights Imaging"},{"issue":"1","key":"1786_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12969-022-00698-3","volume":"20","author":"S Kaut","year":"2022","unstructured":"Kaut\u00a0S, Van den Wyngaert\u00a0I, Christiaens\u00a0D, Wouters\u00a0C, Noppe\u00a0N, Herregods\u00a0N, Dehoorne\u00a0J, De Somer\u00a0L (2022) Chronic nonbacterial osteomyelitis in children: a multicentre Belgian cohort of 30 children. Pediatr Rheumatol Online J 20(1):41\u201341","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"1786_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/mr\/roab103","volume":"32","author":"M Kishimoto","year":"2022","unstructured":"Kishimoto\u00a0M, Taniguchi\u00a0Y, Tsuji\u00a0S, Ishihara\u00a0Y, Deshpande\u00a0GA, Maeda\u00a0K, Okada\u00a0M, Komagata\u00a0Y, Kobayashi\u00a0S, Okubo\u00a0Y, Tomita\u00a0T, Kaname\u00a0S (2022) SAPHO syndrome and pustulotic arthro-osteitis. Mod Rheumatol 32(4):665\u2013674","journal-title":"Mod Rheumatol"},{"issue":"6","key":"1786_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-016-0583-y","volume":"18","author":"D Firinu","year":"2016","unstructured":"Firinu\u00a0D, Garcia-Larsen\u00a0V, Manconi\u00a0PE, Del Giacco\u00a0SR (2016) SAPHO Syndrome: Current Developments and Approaches to Clinical Treatment. Curr Rheumatol Rep 18(6):35","journal-title":"Curr Rheumatol Rep"},{"key":"1786_CR12","unstructured":"ClinicalTrials.gov (2025) Study of the pathophysiological mechanisms involved in the SAPHO syndrome: genetic component and immune response [Internet]. Identifier NCT07081880. https:\/\/clinicaltrials.gov\/study\/NCT07081880. Accessed 13.8.2025"},{"issue":"10","key":"1786_CR13","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00296-009-1136-8","volume":"30","author":"G Assmann","year":"2010","unstructured":"Assmann\u00a0G, Wagner\u00a0AD, Monika\u00a0M, Pf\u00f6hler\u00a0C, Pfreundschuh\u00a0M, Tilgen\u00a0W, Roemer\u00a0K (2010) Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome. Rheumatol Int 30(10):1273\u20131276","journal-title":"Rheumatol Int"},{"issue":"11","key":"1786_CR14","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.1038\/jid.2009.157","volume":"129","author":"T Oudot","year":"2009","unstructured":"Oudot\u00a0T, Lesueur\u00a0F, Guedj\u00a0M, de Cid\u00a0R, McGinn\u00a0S, Heath\u00a0S, Foglio\u00a0M, Prum\u00a0B, Lathrop\u00a0M, Prud\u2019homme\u00a0JF, Fischer\u00a0J (2009) An association study of 22 candidate genes in psoriasis families reveals shared genetic factors with other autoimmune and skin disorders. J\u00a0Invest Dermatol 129(11):2637\u20132645","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1786_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.512","volume":"7","author":"J Qiao","year":"2019","unstructured":"Qiao\u00a0J, Jia\u00a0QN, Jin\u00a0HZ (2019) Lack of association of the IL-1RN and IL-10 polymorphisms with risk of psoriasis: A\u00a0meta-analysis. Mol Genet Genomic Med 7(1):e00512","journal-title":"Mol Genet Genomic Med"},{"issue":"1","key":"1786_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-020-01037-7","volume":"21","author":"G Assmann","year":"2020","unstructured":"Assmann\u00a0G, K\u00f6hm\u00a0M, Schuster\u00a0V, Behrens\u00a0F, M\u00f6ssner\u00a0R, Magnolo\u00a0N, Oji\u00a0V, Burkhardt\u00a0H, H\u00fcffmeier\u00a0U (2020) Genetic variants in FBLIM1 gene do not contribute to SAPHO syndrome and chronic recurrent multifocal osteomyelitis in typical patient groups. BMC Med Genet 21(1):102","journal-title":"BMC Med Genet"},{"issue":"5","key":"1786_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle\u00a0FO, Kaplan\u00a0DH, Barker\u00a0J (2009) Psoriasis. N Engl J Med 361(5):496\u2013509","journal-title":"N Engl J Med"},{"issue":"6","key":"1786_CR18","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00105-023-05148-z","volume":"74","author":"K Technau-Hafsi","year":"2023","unstructured":"Technau-Hafsi\u00a0K, Garzorz-Stark\u00a0N, Eyerich\u00a0K (2023) Molekulare Diagnostik des Handekzems [Molecular diagnosis of hand eczema]. Dermatologie (Heidelb) 74(6):410\u2013415","journal-title":"Dermatologie (Heidelb)"},{"issue":"10","key":"1786_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/exd.13077","volume":"25","author":"N Garzorz-Stark","year":"2016","unstructured":"Garzorz-Stark\u00a0N, Krause\u00a0L, Lauffer\u00a0F, Atenhan\u00a0A, Thomas\u00a0J, Stark\u00a0SP, Franz\u00a0R, Weidinger\u00a0S, Balato\u00a0A, Mueller\u00a0NS, Theis\u00a0FJ, Ring\u00a0J, Schmidt-Weber\u00a0CB, Biedermann\u00a0T, Eyerich\u00a0S, Eyerich\u00a0K (2016) A novel molecular disease classifier for psoriasis and eczema. Exp Dermatol 25(10):767\u2013774","journal-title":"Exp Dermatol"},{"key":"1786_CR20","unstructured":"AWMF S3\u00a0Leitlinie f\u00fcr Diagnose und Management der Psoriasis vulgaris (2025) AWMF S3\u00a0Leitlinie f\u00fcr Diagnose und Management der Psoriasis vulgaris."},{"key":"1786_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-eular.4145","author":"G Assmann","year":"2019","unstructured":"Assmann\u00a0G, Bittenbring\u00a0JT, Wagner\u00a0AD, Schreiber\u00a0M, Christofyllakis\u00a0K (2019) Impact of interleukin 17 blocking agent on clinical outcome in sapho patients. Ann Rheum Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2019-eular.4145","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"1786_CR22","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/jdv.14386","volume":"31","author":"AA Navarini","year":"2017","unstructured":"Navarini\u00a0AA, Burden\u00a0AD, Capon\u00a0F, Mrowietz\u00a0U, Puig\u00a0L, K\u00f6ks\u00a0S, Kingo\u00a0K, Smith\u00a0C, Barker\u00a0JN, ERASPEN Network (2017) European consensus statement on phenotypes of pustular psoriasis. J\u00a0Eur Acad Dermatol Venereol 31(11):1792\u20131799","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"1786_CR23","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.2011.10233.x","volume":"164","author":"U Mrowietz","year":"2011","unstructured":"Mrowietz\u00a0U, van de Kerkhof\u00a0PC (2011) Management of palmoplantar pustulosis: do we need to change? Br J Dermatol 164(5):942\u2013946","journal-title":"Br J Dermatol"},{"issue":"1","key":"1786_CR24","first-page":"13","volume":"98","author":"M Murakami","year":"2020","unstructured":"Murakami\u00a0M, Terui\u00a0T (2020) Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism. J\u00a0Dermatol 98(1):13\u201319","journal-title":"J Dermatol"},{"issue":"Suppl\u00a02","key":"1786_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3899\/jrheum.2024-0592","volume":"51","author":"KC Duffin","year":"2024","unstructured":"Duffin\u00a0KC, Thio\u00a0HB, Helliwell\u00a0PS (2024) Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis, Palmoplantar Pustulosis, and Neutrophilic Dermatoses: A\u00a0GRAPPA 2023 Annual Meeting Update. J\u00a0Rheumatol 51(Suppl\u00a02):77\u201379","journal-title":"J Rheumatol"},{"issue":"2","key":"1786_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jbspin.2017.04.010","volume":"85","author":"JM Berthelot","year":"2018","unstructured":"Berthelot\u00a0JM, Corvec\u00a0S, Hayem\u00a0G (2018) SAPHO, autophagy, IL\u20111, FoxO1, and Propionibacterium (Cutibacterium) acnes. Joint Bone Spine 85(2):171\u2013176","journal-title":"Joint Bone Spine"},{"issue":"7","key":"1786_CR27","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1468-3083.2012.04602.x","volume":"27","author":"SY Yoon","year":"2013","unstructured":"Yoon\u00a0SY, Park\u00a0HS, Lee\u00a0JH, Cho\u00a0S (2013) Histological differentiation between palmoplantar pustulosis and pompholyx. J\u00a0Eur Acad Dermatol Venereol 27(7):889\u2013893","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"1786_CR28","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.ijd_908_21","volume":"68","author":"P Chauhan","year":"2023","unstructured":"Chauhan\u00a0P, Meena\u00a0D, Jindal\u00a0R, Roy\u00a0S, Shirazi\u00a0N (2023) Dermoscopy in the Diagnosis of Palmoplantar Eczema and Palmoplantar Psoriasis: A\u00a0Cross-Sectional, Comparative Study from a\u00a0Tertiary Care Centre in North India. Indian J Dermatol 68(1):120","journal-title":"Indian J Dermatol"},{"issue":"1","key":"1786_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-020-01037-7","volume":"21","author":"G Assmann","year":"2020","unstructured":"Assmann\u00a0G, K\u00f6hm\u00a0M, Schuster\u00a0V, Behrens\u00a0F, M\u00f6ssner\u00a0R et\u00a0al (2020) Genetic variants in FBLIM1 gene do not contribute to SAPHO syndrome and chronic recurrent multifocal osteomyelitis in typical patient groups. BMC Med Genet 21(1):102","journal-title":"BMC Med Genet"},{"issue":"6","key":"1786_CR30","doi-asserted-by":"publisher","first-page":"937","DOI":"10.5114\/ada.2020.97394","volume":"38","author":"H Przepiera-B\u0119dzak","year":"2021","unstructured":"Przepiera-B\u0119dzak\u00a0H, Brzosko\u00a0M (2021) SAPHO syndrome: pathogenesis, clinical presentation, imaging, comorbidities and treatment: a\u00a0review. Postepy Dermatol Alergol 38(6):937\u2013942","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"1786_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/09546634.2015.1052036","volume":"27","author":"M Muro","year":"2016","unstructured":"Muro\u00a0M, Kawakami\u00a0H, Matsumoto\u00a0Y, Abe\u00a0N, Tsuboi\u00a0R, Okubo\u00a0Y (2016) Topical combination therapy with vitamin D3 and corticosteroid ointment for palmoplantar pustulosis: A\u00a0prospective, randomized, left-right comparison study. J\u00a0Dermatolog Treat 27(1):51\u201353","journal-title":"J Dermatolog Treat"},{"issue":"Suppl 2","key":"1786_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1468-3083.2011.03993.x","volume":"25","author":"E Sbidian","year":"2011","unstructured":"Sbidian\u00a0E, Maza\u00a0A, Montaudi\u00e9\u00a0H, Gallini\u00a0A, Aractingi\u00a0S, Aubin\u00a0F et\u00a0al (2011) Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature review. J\u00a0Eur Acad Dermatol Venereol 25(Suppl 2):28\u201333","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"1786_CR33","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/14740338.2020.1785427","volume":"19","author":"WM Wang","year":"2020","unstructured":"Wang\u00a0WM, Jin\u00a0HZ (2020) Biologics in the treatment of pustular psoriasis. Expert Opin Drug Saf 19(8):969\u2013980","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"1786_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003688","volume":"9","author":"SWS Li","year":"2023","unstructured":"Li\u00a0SWS, Roberts\u00a0E, Hedrich\u00a0C (2023) Treatment and monitoring of SAPHO syndrome: a systematic review. RMD Open 9(4):e003688","journal-title":"RMD Open"},{"issue":"5","key":"1786_CR35","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaad.2019.01.066","volume":"80","author":"U Mrowietz","year":"2019","unstructured":"Mrowietz\u00a0U, Bachelez\u00a0H, Burden\u00a0AD, Rissler\u00a0M, Sieder\u00a0C et\u00a0al (2019) Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study. J\u00a0Am Acad Dermatol 80(5):1344\u20131352","journal-title":"J Am Acad Dermatol"},{"key":"1786_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1476793","volume":"11","author":"N Du","year":"2024","unstructured":"Du\u00a0N, Yang\u00a0J, Zhang\u00a0Y, Lv\u00a0X, Cao\u00a0L, Min\u00a0W (2024) Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patients. Front Med (Lausanne) 11:1476793","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"1786_CR37","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s00296-023-05491-3","volume":"44","author":"T Demirci Yildirim","year":"2024","unstructured":"Demirci Yildirim\u00a0T, Sari \u0130 (2024) SAPHO syndrome: current clinical, diagnostic and treatment approaches. Rheumatol Int 44(11):2301\u20132313","journal-title":"Rheumatol Int"},{"key":"1786_CR38","first-page":"33","volume":"13","author":"K Heidemeyer","year":"2023","unstructured":"Heidemeyer\u00a0K, Lee\u00a0M, Cazzaniga\u00a0S, Yawalkar\u00a0N, Naldi\u00a0L (2023) Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies. Psoriasis (Auckl) 13:33\u201358","journal-title":"Psoriasis (Auckl)"},{"key":"1786_CR39","first-page":"733","volume":"28","author":"J Karciauskiene","year":"2014","unstructured":"Karciauskiene\u00a0J, Valiukeviciene\u00a0S, Gollnick\u00a0H et\u00a0al (2014) The prevalence and risk factors of adolescent acne among schoolchildren in Lithuania: a cross-sectional study. JEur AcadDermatol Venereol 28:733\u2013740","journal-title":"JEur AcadDermatol Venereol"},{"key":"1786_CR40","first-page":"301","volume":"111","author":"HP Gollnick","year":"2014","unstructured":"Gollnick\u00a0HP, Zouboulis\u00a0CC (2014) Not all acne is acne vulgaris. Dtsch Arztebl 111:301\u2013312","journal-title":"Dtsch Arztebl"},{"key":"1786_CR41","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/978-3-642-02202-9_143","volume-title":"Textbook of clinical pediatrics","author":"HP Gollnick","year":"2012","unstructured":"Gollnick\u00a0HP (2012) Acne and related disorders. In: Elzouki\u00a0AY (ed) Textbook of clinical pediatrics, 2.\u00a0Aufl\u00a0edn. Springer, Berlin, pp\u00a01447\u20131466","edition":"2.\u00a0Aufl"},{"key":"1786_CR42","volume-title":"Plewig and Kligman\u2019s acne and rosacea","author":"G Plewig","year":"2019","unstructured":"Plewig\u00a0G, Melnik\u00a0B, Chen\u00a0W (2019) Plewig and Kligman\u2019s acne and rosacea, 4.\u00a0Aufl\u00a0edn. Springer, Cham","edition":"4.\u00a0Aufl"},{"key":"1786_CR43","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/jdv.13776","volume":"30","author":"A Nast","year":"2016","unstructured":"Nast\u00a0A, Dr\u00e9no\u00a0B, Bettoli\u00a0V et\u00a0al (2016) European evidence-based (S3) guideline for the treatment of acne - update2016 \u2013 shortversion. J\u00a0Eur Acad Dermatol Venereol 30:1261\u20131268","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1786_CR44","first-page":"1185","volume":"16","author":"B Dreno","year":"2018","unstructured":"Dreno\u00a0B, Bagatin\u00a0E, Blume-Peytavi\u00a0U et\u00a0al (2018) Akne bei erwachsenen Frauen: Physiologische und psychologische Erw\u00e4gungen und Management. J\u00a0Dtsch Dermatol Ges 16:1185\u20131196","journal-title":"J Dtsch Dermatol Ges"},{"issue":"4","key":"1786_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.13190","volume":"29","author":"B Dreno","year":"2015","unstructured":"Dreno\u00a0B, Gollnick\u00a0HPM, Kang\u00a0S et\u00a0al (2015) Understanding innate immunity and inflammation in acne: implications for management. J\u00a0Eur Acad Dermatol Venereol 29(4):3\u201311","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1786_CR46","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1111\/j.1468-3083.2011.04444.x","volume":"26","author":"V Bataille","year":"2012","unstructured":"Bataille\u00a0V, Lens\u00a0M, Spector\u00a0TD (2012) The use of the twin model to investigate the genetics and epigenetics of skin diseases with genomic, transcriptomic and methylation data. J\u00a0Eur Acad Dermatol Venereol 26:1067\u20131073","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1786_CR47","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1111\/jdv.14385","volume":"31","author":"R Lichtenberger","year":"2017","unstructured":"Lichtenberger\u00a0R, Simpson\u00a0MA, Smith\u00a0C et\u00a0al (2017) Genetic architecture of acne vulgaris. J\u00a0Eur Acad Dermatol Venereol 31:1978\u20131990","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1786_CR48","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-019-00423-z","volume":"20","author":"SS Kolli","year":"2019","unstructured":"Kolli\u00a0SS, Pecone\u00a0D, Pona\u00a0A et\u00a0al (2019) Topical retinoids in acne vulgaris: a systematic review. Am J Clin Dermatol 20:345\u2013365","journal-title":"Am J Clin Dermatol"},{"key":"1786_CR49","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2147\/TCRM.S94062","volume":"12","author":"SY Kim","year":"2016","unstructured":"Kim\u00a0SY, Ochsendorf\u00a0FR (2016) New developments in acne treatment: role of combination adapalene-benzoylperoxide. Ther Clin RiskManag 12:1497\u20131506","journal-title":"Ther Clin RiskManag"},{"key":"1786_CR50","first-page":"964","volume":"14","author":"BC Schulte","year":"2015","unstructured":"Schulte\u00a0BC, Wu\u00a0W, Rosen\u00a0T (2015) Azelaic acid: evidence-based update on mechanism of action and clinical application. J\u00a0Drugs Dermatol 14:964\u2013968","journal-title":"J Drugs Dermatol"},{"key":"1786_CR51","first-page":"1319","volume":"14","author":"HPM Gollnick","year":"2016","unstructured":"Gollnick\u00a0HPM, Buer\u00a0J, Beissert\u00a0S et\u00a0al (2016) Verantwortlicher Umgang mit Antibiotika: Notwendigkeit der Antibiotikareduktion in der Aknetherapie. J\u00a0Dtsch Dermatol Ges 14:1319\u20131327","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"1786_CR52","first-page":"S31","volume":"8","author":"F Ochsendorf","year":"2010","unstructured":"Ochsendorf\u00a0F (2010) Systemic antibiotic therapy of acne vulgaris. JDtschDermatol Ges 8(1):S31\u2013S46","journal-title":"JDtschDermatol Ges"},{"key":"1786_CR53","first-page":"538","volume":"11","author":"HP Gollnick","year":"2001","unstructured":"Gollnick\u00a0HP, Graupe\u00a0K, Zaumseil\u00a0RP (2001) Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 11:538\u2013544","journal-title":"Eur J Dermatol"},{"key":"1786_CR54","first-page":"565","volume":"16","author":"B Dr\u00e9no","year":"2006","unstructured":"Dr\u00e9no\u00a0B, Bettoli\u00a0V, Ochsendorf\u00a0F et\u00a0al (2006) An expert view on the treatment of acne with systemic antibiotics and\/or oral isotretinoin in the light of the new European recommendations. Eur J Dermatol 16:565\u2013571","journal-title":"Eur J Dermatol"},{"issue":"Suppl 5","key":"1786_CR55","first-page":"S1","volume":"10","author":"CC Zouboulis","year":"2012","unstructured":"Zouboulis\u00a0CC, Bechara\u00a0FG, Fritz\u00a0K, Kurzen\u00a0H, Likakou\u00a0AI, Marsch\u00a0W, Milling\u00a0A, Nast\u00a0A, Podda\u00a0M, Taube\u00a0KM, Wienert\u00a0V, Winkler\u00a0T (2012) S1-Leitlinie zur Therapie der Hidradenitis suppurativa\/Akne inversa (ICD-10 Ziffer L73.2). JDDG 10(Suppl 5):S1\u201331","journal-title":"JDDG"},{"issue":"12","key":"1786_CR56","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00105-017-4082-5","volume":"68","author":"R Sabat","year":"2017","unstructured":"Sabat\u00a0R, Tsaousi\u00a0A, Rossbacher\u00a0J, Kurzen\u00a0H, Fadai\u00a0T, Schwichtenberg\u00a0U, Schneider-Burrus\u00a0S (2017) Acne inversa\/hidradenitis suppurativa: an update. Hautarzt 68(12):999\u20131006","journal-title":"Hautarzt"},{"issue":"2","key":"1786_CR57","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMcp1014163","volume":"366","author":"GBE Jemec","year":"2012","unstructured":"Jemec\u00a0GBE (2012) Hidradenitis suppurativa. NEngl J Med 366(2):158\u2013164","journal-title":"NEngl J Med"},{"issue":"2","key":"1786_CR58","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/1203475417746122","volume":"22","author":"L Scholl","year":"2018","unstructured":"Scholl\u00a0L, Hessam\u00a0S, Bergmann\u00a0U, Bechara\u00a0FG (2018) Surgical Treatment of Sinus Tracts and Fistulas in Perianal Hidradenitis Suppurativa. J\u00a0Cutan Med Surg 22(2):239\u2013241","journal-title":"J Cutan Med Surg"},{"key":"1786_CR59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/120347540300700109","volume":"7","author":"GBE Jemec","year":"2003","unstructured":"Jemec\u00a0GBE (2003) Hidradenitis suppurativa. J\u00a0Cutan Med Surg 7:47\u201356","journal-title":"J Cutan Med Surg"},{"key":"1786_CR60","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/bjd.15939","volume":"178","author":"A Garg","year":"2018","unstructured":"Garg\u00a0A, Papagermanos\u00a0V, Midura\u00a0M, Strunk\u00a0A (2018) Incidence of hidradenitis suppurativa among tobacco smokers: a\u00a0population-based retrospective analysis in the U.S.A. Br J Dermatol 178:709\u2013714","journal-title":"Br J Dermatol"},{"key":"1786_CR61","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/bjd.15255","volume":"176","author":"JR Ingram","year":"2017","unstructured":"Ingram\u00a0JR, Burton\u00a0T (2017) NICE approval of adalimumab for moderate to-severe hidradenitis suppurativa: the end of the beginning for hidradenitis suppurativa therapeutics? Br J Dermatol 176:281\u2013282","journal-title":"Br J Dermatol"},{"key":"1786_CR62","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/j.1600-0625.2012.01552.x","volume":"21","author":"HH Van der Zee","year":"2012","unstructured":"Van der Zee\u00a0HH, Laman\u00a0JD, Boer\u00a0J, Prens\u00a0EP (2012) Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments. Exp Dermatol 21:735\u2013739","journal-title":"Exp Dermatol"},{"issue":"3","key":"1786_CR63","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/bjd.16019","volume":"178","author":"S Hessam","year":"2018","unstructured":"Hessam\u00a0S, Sand\u00a0M, Gambichler\u00a0T, Skrygan\u00a0M, R\u00fcddel\u00a0I, Bechara\u00a0FG (2018) Interleukin-36 in hidradenitis suppurativa: evidence for a\u00a0distinctive proinflammatory role and a\u00a0key factor in the development of an inflammatory loop. Br J Dermatol 178(3):761\u2013767","journal-title":"Br J Dermatol"},{"issue":"1","key":"1786_CR64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/jdv.16962","volume":"35","author":"S Hessam","year":"2021","unstructured":"Hessam\u00a0S, Gambichler\u00a0T, Skrygan\u00a0M, Scholl\u00a0L, Sand\u00a0M, Meyer\u00a0T, Stockfleth\u00a0E, Bechara\u00a0FG (2021) Increased expression profile of NCSTN, Notch and PI3K\/AKT3 in hidradenitis suppurativa. J\u00a0Eur Acad Dermatol Venereol 35(1):203\u2013210","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1786_CR65","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","volume":"17","author":"H Kurzen","year":"2008","unstructured":"Kurzen\u00a0H, Kurokawa\u00a0I, Jemec\u00a0GBE et\u00a0al (2008) What causes hidradenitis suppurativa? Exp Dermatol 17:455\u2013472","journal-title":"Exp Dermatol"},{"key":"1786_CR66","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000431175","volume":"231","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis\u00a0CC, del Marmol\u00a0V, Mrowietz\u00a0U, Prens\u00a0E, Tzellos\u00a0T, Jemec\u00a0GBE (2015) Hidradenitis suppurativa\/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation. Dermatology 231:184\u2013190","journal-title":"Dermatology"},{"key":"1786_CR67","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","volume":"59","author":"JE Revuz","year":"2008","unstructured":"Revuz\u00a0JE, Canoui-Poitrine\u00a0F, Wolkenstein\u00a0P et\u00a0al (2008) Prevalence and factors associated with hidradenitis suppurativa: results from two case control studies. J\u00a0Am Acad Dermatol 59:596\u2013601","journal-title":"J Am Acad Dermatol"},{"key":"1786_CR68","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2340\/00015555-1800","volume":"94","author":"CB Kromann","year":"2014","unstructured":"Kromann\u00a0CB, Ibler\u00a0KS, Kristiansen\u00a0VB, Jemec\u00a0GBE (2014) The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol 94:553\u2013557","journal-title":"Acta Derm Venereol"},{"key":"1786_CR69","unstructured":"Kimball AB et\u00a0al. (2020) virtuelle Jahrestagung der American Acacemy of Dermatology (AAD). Poster # P16480."},{"issue":"3","key":"1786_CR70","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2340\/00015555-2513","volume":"97","author":"B Horv\u00e1th","year":"2017","unstructured":"Horv\u00e1th\u00a0B, Janse\u00a0IC, Blok\u00a0JL, Driessen\u00a0RJB, Boer\u00a0J, Mekkes\u00a0JR, Prens\u00a0EP, van der Zee\u00a0HH (2017) Hurley staging refined: A proposal by the Dutch Hidradenitis Suppurativa Expert Group. Acta Derm Venereol 97(3):412\u2013413","journal-title":"Acta Derm Venereol"},{"key":"1786_CR71","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0190-9622(98)70272-5","volume":"39","author":"GB Jemec","year":"1998","unstructured":"Jemec\u00a0GB, Wendelboe\u00a0P (1998) Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J\u00a0Am Acad Dermatol 39:971\u2013974","journal-title":"J Am Acad Dermatol"},{"key":"1786_CR72","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jaad.2020.12.089","volume":"85","author":"KR van Straalen","year":"2021","unstructured":"van Straalen\u00a0KR, Tzellos\u00a0T, Guillem\u00a0P et\u00a0al (2021) The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study. J\u00a0Am Acad Dermatol 85:369\u2013378","journal-title":"J Am Acad Dermatol"},{"key":"1786_CR73","volume":"21","author":"JS Kirby","year":"2023","unstructured":"Kirby\u00a0JS, Okun\u00a0MM, Alavi\u00a0A, Bechara\u00a0FG, Zouboulis\u00a0CC, Brown\u00a0K, Santos\u00a0LL, Wang\u00a0A, Bibeau\u00a0KB, Kimball\u00a0AB, Porter\u00a0ML (2023) Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study. J\u00a0Am Acad Dermatol 21:S0190\u20139622(23)03037\u20112","journal-title":"J Am Acad Dermatol"},{"key":"1786_CR74","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1111\/jdv.14464","volume":"31","author":"J Gasparic","year":"2017","unstructured":"Gasparic\u00a0J, Theut Riis\u00a0P, Jemec\u00a0GB (2017) Recognizing syndromic hidradenitis suppurativa: a review of the literature. J\u00a0Eur Acad Dermatol Venereol 31:1809\u20131816","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1786_CR75","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/jdv.12631","volume":"30","author":"N Garzorz","year":"2016","unstructured":"Garzorz\u00a0N, Papanagiotou\u00a0V, Atenhan\u00a0A, Andres\u00a0C, Eyerich\u00a0S, Eyerich\u00a0K, Ring\u00a0J, Brockow\u00a0K (2016) Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes? J\u00a0Eur Acad Dermatol Venereol 30:141\u2013143","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1786_CR76","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/bjd.17578","volume":"180","author":"H Tiri","year":"2019","unstructured":"Tiri\u00a0H, Jokelainen\u00a0J, Timonen\u00a0M, Tasanen\u00a0K, Huilaja\u00a0L (2019) Substantially reduced life expectancy in patients with hidradenitis suppurativa: a\u00a0Finnish nationwide registry study. Br J Dermatol 180(6):1543\u20131544","journal-title":"Br J Dermatol"},{"issue":"5","key":"1786_CR77","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s00393-021-00979-4","volume":"80","author":"P Klemm","year":"2021","unstructured":"Klemm\u00a0P, Lange\u00a0U (2021) SAPHO syndrome : An overview and nosological differentiation of 35 disease cases. Z Rheumatol 80(5):456\u2013466","journal-title":"Z Rheumatol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-026-01786-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-026-01786-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-026-01786-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T17:02:52Z","timestamp":1772470972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-026-01786-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":77,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1786"],"URL":"https:\/\/doi.org\/10.1007\/s00393-026-01786-5","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Alter mit Honoraren f\u00fcr advisory boards von: Roche, BMS, MSD, Novartis, Amgen, Merck Serono, Almirall Hermal, SUN, Sanofi, Pierre-Fabre, Abbvie, Janssen, Pfizer, Takeda, Incyte, Falk; Drittmittel-finanzierte Kongressteilnahmen durch: Roche, Novartis, BMS, SUN, Merck-Serono, Pierre-Fabre, AbbVie, UCB. G.\u00a0Assmann mit Honoraren f\u00fcr advisory boards, Forschungsf\u00f6rderung und Kongresssponsoring von: Novartis, AbbVie, Janssen, Pfizer, UCB. C.\u00a0M\u00fcller, C.\u00a0Pfoehler und L.\u00a0Susok geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}